Cowley, Hannah Paris
Robinette, Michael S.
Matelsky, Jordan K.
Xenes, Daniel
Kashyap, Aparajita
Ibrahim, Nabeela F.
Robinson, Matthew L.
Zeger, Scott
Garibaldi, Brian T.
Gray-Roncal, William
Funding for this research was provided by:
Hopkins inHealth
The Johns Hopkins Precision Medicine Program
Article History
Received: 17 December 2021
Accepted: 13 December 2022
First Online: 8 February 2023
Competing interests
: Dr. Garibaldi is a member of the FDA Pulmonary-Asthma Drug Advisory Committee and has received consulting fees from Janssen Research and Development, LLC, Gilead Sciences, Inc and Atea Pharmaceuticals, Inc. All other authors declare no competing interests.